Kajian klinikal Mania di California
5 kajian untuk Mania sedang mencari peserta di lokasi di California.
Bandar di California
Teks kajian rasmi (Bahasa Inggeris)
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
- Neurocrine Clinical Site, Cerritos
- Neurocrine Clinical Site, Garden Grove
- Neurocrine Clinical Site, San Diego
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07288320A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
- Proscience Research Group, Culver City
- Clinical Innovations, Inc. dba CITrials, Riverside
- Collaborative Neuroscience Research, LLC, Torrance
Mengambil pesertaFasa 3
Umur 18 hingga 65 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06951711A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
- Advanced Research Center Inc., Anaheim
- CITrials, Bellflower
- Local Institution - 0014, Cerritos
- dan 3 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 65 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06951698A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
- Advanced Research Center Inc., Anaheim
- Clinical Innovations, Inc. dba CITrials, Bellflower
- Local Institution - 0044, Cerritos
- dan 10 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 65 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06929273A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- Clinical Innovations, Inc. dba CITrials, Bellflower
- Inland Psychiatric Medical Group., Chino
- Proscience Research Group, Culver City
- dan 4 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 65 · Semua jantina · Dikemas kini 23 Jun 2026 · NCT07140913Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.